Farglitazar - CISMeF

Preferred Label : Farglitazar;

NCIt definition : An L-tyrosine derived and peroxisome proliferator-activated receptor (PPAR) agonist with hypoglycemic and lipid lowering activity. Farglitazar shows greater selectivity over PPARgamma than PPARalpha. This agent is developed for the treatment of hepatic fibrosis.;

UNII : 3433GY7132;

InChIKey : ZZCHHVUQYRMYLW-HKBQPEDESA-N;

CAS number : 196808-45-4;

Molecule name : GI262570;

Chemical formula : C34H30N2O5;

Details

Origin ID

C81693;

UMLS CUI

C1447907;

Currated CISMeF NLP mapping
- farglitazar [MeSH concept]
- farglitazar [MeSH Supplementary Concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- farglitazar [MeSH Supplementary Concept]
- farglitazar [MeSH concept]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients